Trial · NCT02224664
Participant flow30
How many started, completed or left each group, period by period.
1 to 20 of 30
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Lead-in Period (3 Days) | STARTED | L-Dopa | 50 | |
| Lead-in Period (3 Days) | STARTED | PF-06649751 5 mg + L-Dopa | 0 | |
| Lead-in Period (3 Days) | STARTED | PF-06649751 15 mg + L-Dopa | 0 | |
| Lead-in Period (3 Days) | STARTED | PF-06649751 15 mg + L-Dopa: L-dopa Induced Dyskinesia (LID) | 0 | |
| Lead-in Period (3 Days) | STARTED | PF-06649751 25 mg + L-Dopa | 0 | |
| Lead-in Period (3 Days) | COMPLETED | L-Dopa | 45 | |
| Lead-in Period (3 Days) | COMPLETED | PF-06649751 5 mg + L-Dopa | 0 | |
| Lead-in Period (3 Days) | COMPLETED | PF-06649751 15 mg + L-Dopa | 0 | |
| Lead-in Period (3 Days) | COMPLETED | PF-06649751 15 mg + L-Dopa: L-dopa Induced Dyskinesia (LID) | 0 | |
| Lead-in Period (3 Days) | COMPLETED | PF-06649751 25 mg + L-Dopa | 0 | |
| Lead-in Period (3 Days) | NOT COMPLETED | L-Dopa | 5 | |
| Lead-in Period (3 Days) | NOT COMPLETED | PF-06649751 5 mg + L-Dopa | 0 | |
| Lead-in Period (3 Days) | NOT COMPLETED | PF-06649751 15 mg + L-Dopa | 0 | |
| Lead-in Period (3 Days) | NOT COMPLETED | PF-06649751 15 mg + L-Dopa: L-dopa Induced Dyskinesia (LID) | 0 | |
| Lead-in Period (3 Days) | NOT COMPLETED | PF-06649751 25 mg + L-Dopa | 0 | |
| Dose Escalation Period (21 Days) | STARTED | L-Dopa | 0 | |
| Dose Escalation Period (21 Days) | STARTED | PF-06649751 5 mg + L-Dopa | 9 | |
| Dose Escalation Period (21 Days) | STARTED | PF-06649751 15 mg + L-Dopa | 11 | |
| Dose Escalation Period (21 Days) | STARTED | PF-06649751 15 mg + L-Dopa: L-dopa Induced Dyskinesia (LID) | 6 | |
| Dose Escalation Period (21 Days) | STARTED | PF-06649751 25 mg + L-Dopa | 19 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02224664/flow